| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |